Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.

Kirkpatrick WR, Revankar SG, Mcatee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, Sanche SE, Cantu RA, Rinaldi MG, Patterson TF. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates. J Clin Microbiol. 1998 Oct; 36(10):3007-12.

View in: PubMed

subject areas

AIDS-Related Opportunistic Infections
Amphotericin B
Antifungal Agents
Candida
Candidiasis, Oral
Fluconazole
Genotype
HIV Infections
Humans
Itraconazole
Microbial Sensitivity Tests
Mouth
North America
Pharynx
Phenotype
Pyrimidines
Triazoles

authors with profiles

Jose L. Lopez-Ribot

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support